Study Stopped
New data has caused the principal investigator to decide that the study no longer makes sense to conduct as it is designed. This is not a suspension of IRB approval.
Augmenting rTMS With Cognitive Control Training in Major Depressive Disorder
Augmenting Repetitive Transcranial Magnetic Stimulation (rTMS) With Cognitive Control Training in Major Depressive Disorder (MDD)
1 other identifier
interventional
4
1 country
1
Brief Summary
Repetitive transcranial magnetic stimulation (rTMS) is an effective treatment for MDD, but the overall effect sized of the treatment is equivalent to antidepressant pharmacotherapy, and responses are highly variable. Given that rTMS is usually given to patients who have failed pharmacotherapy, a more effective alternative is needed. Therefore, this study will combine computerized cognitive training (CCT) during standard rTMS treatments and assess its feasibility, tolerability, and changes in cognitive control performance and depression symptoms. Participants that agree to the study and meet eligibility will receive standard rTMS (generally 25-36 daily treatments) along with CCT (starting on day 5 of treatment until the pre-taper treatment). In addition, to CCT participants will be asked to complete assessments before and after treatment
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable major-depressive-disorder
Started Aug 2019
Shorter than P25 for not_applicable major-depressive-disorder
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 27, 2019
CompletedFirst Submitted
Initial submission to the registry
March 19, 2020
CompletedFirst Posted
Study publicly available on registry
March 23, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2021
CompletedApril 8, 2021
April 1, 2021
1.6 years
March 19, 2020
April 5, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Feasibility assessed by percentage of CCT sessions completed during rTMS
Percentage CCT sessions completed: (number of sessions completed/number of sessions assigned) X 100
approximately 30 days (usually 20-30 sessions)
Secondary Outcomes (3)
Time on task during treatment
For each day: 45 min; for entire treatment: approx 30 days
Acceptability of CCT
through study completion date, up to 2 years
Cognitive Control Performance change over course of treatment
Approximately 30 days (usually 20-30 sessions)
Study Arms (1)
Computerized Cognitive Training (CCT)
EXPERIMENTALThe patients will receive CCT during their standard rTMS treatments (after having 5 days of treatment until the pre-taper treatment).
Interventions
After having four rTMS sessions without CCT, the patients will perform CCT (starting day 5) during the rTMS session, which typically last from 20-40 minutes. A course of rTMS therapy includes from 25-36 treatments, given daily, until the last 5-6 treatments, given as a 'taper' over 2 weeks. CCT will be paired with rTMS up until the taper begins. In addition, they will have assessments prior to and after the therapy.
Eligibility Criteria
You may qualify if:
- Diagnosis of major depressive disorder
- Eligible to receive and recommended for rTMS for depression
- Willingness to complete computerized cognitive training and undergo brain stimulation procedures
- Must be enrolled as a Michigan Medicine patient and currently receiving TMS treatment as part of your clinical care.
You may not qualify if:
- History of serious neurological illness or brain injury (e.g., stroke)
- Poor visual acuity impairing performance on the computerized tasks (eyeglasses must be removed for rTMS treatment, but contacts are permissible)
- Diagnosed intellectual disability
- Inability to manipulate a tablet device while seated in the rTMS chair
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Michigan
Ann Arbor, Michigan, 48109, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Stephan Taylor, MD
University of Michigan
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Psychiatry
Study Record Dates
First Submitted
March 19, 2020
First Posted
March 23, 2020
Study Start
August 27, 2019
Primary Completion
April 1, 2021
Study Completion
April 1, 2021
Last Updated
April 8, 2021
Record last verified: 2021-04
Data Sharing
- IPD Sharing
- Will not share